EndoSonics improves catheter imaging
EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the “Avanar.” The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and
EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the Avanar. The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and definitive morphologic assessment, according to the firm. The device is part of EndoSonics digital intravascular ultrasound product line.
The Avanar has a smaller profile to allow easier and more rapid access through stents; tight lesions; and small, tortuous arteries. Reinhard J. Warnking, CEO and president of EndoSonics, said 80% of his companys revenue comes from sales of disposable products such as the Avanar. EndoSonics is a Rancho Cordova, CA-based developer, manufacturer, and marketer of intravascular ultrasound imaging products.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
